Literature DB >> 14003433

Methylhydrazine derivatives, a new class of cytotoxic agents.

P ZELLER, H GUTMANN, B HEGEDUS, A KAISER, A LANGEMANN, M MULLER.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; HYDRAZINES

Mesh：

Substances：

Year:  1963        PMID： 14003433     DOI： 10.1007/bf02171588

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  2 in total

1.  The degradation of deoxyribonucleic acid by new tumour inhibiting compounds: the intermediate formation of hydrogen peroxide.

Authors:  K BERNEIS; M KOFLER; W BOLLAG; A KAISER; A LANGEMANN
Journal:  Experientia       Date:  1963-03-15

2.  Tumour inhibitory effects of a new class of cytotoxic agents: methylhydrazine derivatives.

Authors:  W BOLLAG; E GRUNBERG
Journal:  Experientia       Date:  1963-03-15
  2 in total
  14 in total

1.  NATULAN IN MANAGEMENT OF LATE HODGKIN'S DISEASE, OTHER LYMPHORETICULAR NEOPLASMS, AND MALIGNANT MELANOMA.

Authors:  I D TODD
Journal:  Br Med J       Date:  1965-03-06

2.  [ON THE METABOLISM OF A CYTOSTATIC METHYLHYDRAZINE DERIVATIVE (NATULAN)].

Authors:  J RAAFLAUB; D E SCHWARTZ
Journal:  Experientia       Date:  1965-01-15

3.  [The cytostatic action mechanism of Natulan].

Authors:  G Weitzel; F Schneider; D Kummer; H Ochs
Journal:  Z Krebsforsch       Date:  1968

4.  [The inhibition of nucleic acid synthesis and transplantibility of Ehrlich ascites tumor cells by natulan, trenimon and p-benzoquinone].

Authors:  F Hölzel; E Wulfmeyer; I Schwencke; H Maass
Journal:  Z Krebsforsch       Date:  1967

5.  An antineoplastic C14-labeled methylhydrazine derivative in P815 mouse leukemia. A metabolic study.

Authors:  W Kreis; W Yen
Journal:  Experientia       Date:  1965-05-15

6.  [Cytostatic mechanism of action of methylhydrazine].

Authors:  G Weitzel; F Schneider; A M Fretzdorff
Journal:  Experientia       Date:  1964-01-15

7.  Methylazo and methylazoxy compounds; new types of antitumour agents.

Authors:  W Bollag; A Kaiser; A Langemann; P Zeller
Journal:  Experientia       Date:  1964-09-15

8.  Catalysis and inhibition of the oxidative degradation of deoxyribonucleic acid by catalase showing maximum catalytic effect in pico-molar concentrations.

Authors:  K Berneis
Journal:  Experientia       Date:  1967-02-15

Review 9.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  The in vivo cytotoxic activity of procarbazine and procarbazine metabolites against L1210 ascites leukemia cells in CDF1 mice and the effects of pretreatment with procarbazine, phenobarbital, diphenylhydantoin, and methylprednisolone upon in vivo procarbazine activity.

Authors:  D A Shiba; R J Weinkam
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.